Latest News - CRSToday

Tuesday, July 25, 2017 | Medical Studies, American Academy of Ophthalmology

Scientists Zero In On Key Protein Driving HSV-1 Inflammation

Scientists from the University of Illinois at Chicago have identified the enzyme heparanase as the crucial factor involved in herpes simplex (HSV-1)-associated corneal inflammation. The heterodimer pr…

Read the full story

Tuesday, July 25, 2017 | Product Releases

Vance Thompson Vision First in the United States to Perform Cataract Surgery with Zepto

Vance Thompson Vision will be the first center in the United States to utilize Zepto in conjunction with Refractive Laser-Assisted Cataract Surgery, or ReLACS. This technology uses low-energy pulses t…

Read the full story

Monday, July 24, 2017 | Acquisitions/Mergers, Essilor

Antitrust Process Update for the Proposed Combination Between Essilor and Luxottica

The proposed combination between Essilor and Luxottica continues to progress, with the antitrust process advancing in all jurisdictions. Essilor and Luxottica have jointly filed with the antitrust aut…

Read the full story

Monday, July 24, 2017 | Clinical Trials, Glaucoma, BioLight

BioLight Reports Successful Results in Phase 1/2a Clinical Trial for Glaucoma Insert

BioLight Life Sciences announced successful results from its glaucoma insert VS101 (Eye-D latanoprost insert) phase 1/2a clinical trial, which demonstrated its ability to lower IOP for a 12-week perio…

Read the full story

Monday, July 24, 2017 | Medical Studies

Too Little Vitamin D May Hinder Recovery of Injured Corneas

Injury or disease in combination with too little vitamin D can be bad for the window to your eyes. The three-layer, transparent cornea at the front of the eyes focuses the light coming in. But its pro…

Read the full story

Monday, July 24, 2017 | Product Releases

Cenegermin Eye Drops For the Treatment of Neurotrophic Keratitis Receive European Union Approval

Dompe announced that the European Commission has granted the marketing authorization of cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis. This makes it the first bio…

Read the full story

Monday, July 24, 2017 | Acquisitions/Mergers

Private Equity-Backed Eyeconic Vision Partners Acquires Swagel-Wootton Hiatt Eye Center

Cortec Group, a New York-based private equity firm which invests in middle-market specialty healthcare, business-to-business and consumer products, and services businesses, announced that on July 6, 2…

Read the full story

Friday, July 21, 2017 | CE Mark Approval, Dry Eye, TearLab Corp.

TearLab Announces European Regulatory Clearance for Next-Generation TearLab Discovery System

TearLab announced that the commercial version of its next-generation in-vitro diagnostics testing platform, the TearLab Discovery System, has received CE Marking, providing clearance in the European U…

Read the full story

Friday, July 21, 2017 | Dry Eye, Medical Studies

TFOS DEWS II Report Published; Dry Eye Disease Redefined

The long-awaited Tear Film & Ocular Surface Society (TFOS) Dry Eye Workshop II (DEWS II) report was published on July 21, 2017, updating the definition of dry eye disease (DED) and potentially imp…

Read the full story

Friday, July 21, 2017 | Medical Studies

Zika: Check All Potentially Exposed Infants for Eye Damage

New research suggests that all infants with possible maternal Zika virus exposure should undergo eye exams regardless of timing of exposure, laboratory confirmation, or whether they have central nervo…

Read the full story

Thursday, July 20, 2017 | Medical Studies, Prevent Blindness

Eye Problems That Are Detected and Treated Early Can Help Kids in the Classroom and Beyond

As children in most parts of the country head back to school, Prevent Blindness, the nation’s oldest non-profit eye health and safety group, asks all parents and caregivers to set their child on…

Read the full story

Thursday, July 20, 2017 | Earnings & Financials, Kala Pharmaceuticals

Kala Pharmaceuticals Announces Pricing of Initial Public Offering

Kala Pharmaceuticals announced that is has priced its initial public offering of 6,000,000 shares of its common stock at a public offering price of $15 per share, for aggregate gross proceeds of appro…

Read the full story

Thursday, July 20, 2017 | Acquisitions/Mergers

Quidel Announces Definitive Agreement to Acquire Alere Triage Assets

Quidel, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into definitive agreements to acquire the…

Read the full story

Wednesday, July 19, 2017 | Clinical Trials, Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive Roclatan Phase 3, 12-Month Topline Safety Results

Aerie Pharmaceuticals reported the successful 12-month safety results of the company’s “Mercury 1” phase 3 registration trial for its fixed-dose combination product candidate, Roclat…

Read the full story

Wednesday, July 19, 2017 | Product Releases

Google Glass is Back, With a New Vision

Google is taking another stab at reviving one of its most high-profile flops. Five years ago, Google unveiled Google Glass, a futuristic gadget with the promise of changing how consumers take pictures…

Read the full story
Load More